CAS: 5333-42-6; 2-Octyldodecan-1-Ol

该化合物是使用化学配方C20H42O的长链长链脂肪酒精, 通常在化妆品和个人护理配方中用作感化和粘度修饰剂, 因为它的传播特性极佳,而且波动性低. 化合物的支流结构增强了稳定性并减少了凝固性, 使其适合用于奶油, 润滑剂和防晒霜. 它的高分子重量有助于成品的长期湿润和改良纹理. 此外, 2-octyldodecane-1 ol 与其他化妆品成分的兼容性, 确保其配制灵活性. 它的不刺激性进一步支持其在敏感的皮肤应用中使用.

结构式图片

相似化合物

104-76-7 2425-77-6 3913-02-8

欧盟法规

REACH注册ECHA物质ECHA物质C&L通报REACH预注册

上下游产品

CAS号112-30-1 正癸醇 | CAS号7440-02-0 镍 | CAS号872-05-9 正癸烯 | CAS号112-31-2 癸醛 | CAS号100-51-6 苯甲醇 | CAS号91-17-8 十氢萘 | CAS号13287-24-6 Nonadecane, 9-methyl | CAS号1260685-63-9 3,6-双(5-溴噻吩-2-基... | CAS号74051-84-6 2-°Ctyldodecyl ... | CAS号78204-54-3 2-辛基-1-十二烷醇硫酸氢 | CAS号62281-06-5 2-正辛基-1-十二胺 | CAS号40596-46-1 2-°Ctyldodecano... | CAS号86218-06-6 2-°Ctyldodecano...

合成工艺路线路线简述

  • 合成目标产物 2-Octyl-1-Dodecanol 主要起始原料 1-Decanol And Nickel
  • (文献来源)合成步骤主要原料 1-Decanol 和 Nickel
Methyl 2-octyldodecanoate置于lithium Aluminium Tetrahydride体系中,用 四氢呋喃 作为反应溶剂,化学反应 2.0H,以86%的收率获得产物2-辛基十二醇
参考文献:一种分叉型卤代烷基链化合物的制备方法及其应用
标题:一种分叉型卤代烷基链化合物的制备方法及其应用
摘要:本发明公开了一种分叉型卤代烷基链化合物的制备方法及其应用,该方法为:溴代烷烃和丙二酸二甲酯反应得到单支链丙二酸二甲酯;溴代烷烃和所得单支链丙二酸二甲酯反应得到双支链丙二酸二甲酯;所得双支链丙二酸二甲酯选择性水解脱羧得到水解产物;所得水解产物还原得到伯醇;所得伯醇进行溴代反应得到溴代物;所得溴代物与环氧乙烷反应得到碳链延长的伯醇化合物;所得碳链延长的伯醇化合物再次进行卤代反应,得到r为相应卤原子的分叉卤代烷基链化合物.该方法为成本低,收率高,操作简便,易于实现产业化的制备工艺.通过在有机共轭聚合物上引入不同分叉长度的烷基链,有效的减少了聚合物间的π‑π堆积距离,提高了聚合物的迁移率.

海关参考信息

专利信息


专利号:US-2021130409-A1
优先权日:2017-09-01
标 题 :Method for the Solid-Phase Synthesis of Cyclic Pentapeptides
发明人:ZHENGGUO JIANG; LUCIANO FORNI; ROBERTSON ALAN
权利人:Alsonex Pty Ltd
摘要:A method for the synthesis of a cyclic ornithine-proline-D-cyclohexylalanine-tryptophan-arginine pentapeptide of Formula A; n n n n n n n n n n n n wherein R 1 and R 2 are, independently, —H, or —C(O)R 3 where R 3 is —CH 2 Ph, —CH 2 CH 2 Ph, —CHâ•?CHPh, —C(NHAC)CH 2 Ph;n nthe method comprising the steps of;n nforming a linear proline-D-cyclohexylalanine-tryptophan-arginine-ornithine pentapeptide of Formula B, attached to a polymeric resin;n n n n n n n n n n n n n n n n n wherein R 1 is as for Formula A, RES indicates the polymeric resin, and P 1 and P 2 are protecting groups;n ncyclising the linear pentapeptide of Formula B to form a cyclic pentapeptide of Formula C, attached to the polymeric resin;n n n n n n n n n n n n n n n cleaving the cyclic peptide of Formula C from the resin providing a cleaved cyclic pentapeptide having a free amine group of an ornithine residue;n noptionally substituting the free amine group of the ornithine residue of the cleaved cyclic peptide;n nremoving the protecting groups P 1 and P 2 , to providethe cyclic peptide of Formula A.

专利号:US-9512096-B2
优先权日:2011-12-22
标题 :Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
发明人:CHEN WEIRONG; HUMORA MICHAEL; KWOK DAW-LONG ALBERT; KIESMAN WILLIAM F; IRDAM ERWIN AYANDRA
权利人:KNOPP BIOSCIENCES LLC; KNOPP BIOSCIENCES LLP
摘要:The present invention is related to an improved process for the preparation of amino-substituted 4,5,6,7-tetrahydrobenzothiazole compounds of formula I, such as the compound 2-amino-4,5,6,7-tetrahydro-6-(n-propylamino)benzothiazole. The invention further relates to an improved synthesis of (R)-2-amino-4,5,6,7-tetrahydro-6-(n-propylamino)benzothiazole. The invention also relates to the methods and intermediates associated with the synthetic process.

专利号:US-9315483-B2
优先权日:2007-09-13
标题 :Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof
发明人:JONES ANDREW D; ZELLE ROBERT E; SILVERMAN I ROBERT
权利人:CONCERT PHARMACEUTICALS INC
摘要:The present invention provides a convenient and efficient process for the synthesis of d 2 -benzo[d][1,3]dioxoles.

专利号:US-7598291-B2
优先权日:2004-09-02
标题 :Methods and compositions for enhancing collagen and proteoglycan synthesis in the skin
发明人:NIMNI MARCEL; HAN BO
权利人:NIMNI MARCEL; HAN BO
摘要:A composition for application to the skin can stimulate the in vivo synthesis of collagen and proteoglycans and improve the appearance of the skin, increasing its elasticity and fullness. In general, a composition according to the present invention comprises: (1) an antioxidant compound in a quantity sufficient to enhance collagen synthesis in the skin; (2) an organic penetrant in which the antioxidant compound is soluble in a sufficient quantity that a concentration of the antioxidant compound sufficient to enhance collagen synthesis can be applied topically and penetrate the skin; (3) a mixture of essential amino acids; (4) a supplemental source of sulfur; and (5) a topical pharmaceutically acceptable carrier. The antioxidant compound can be lipoic acid, a lipoic acid analogue or derivative, a bioflavonoid, a constituent of ginkgo, or an isoflavone. The organic penetrant is preferably benzyl alcohol. Other ingredients, such as esters of tocopherol and ascorbic acid, can be included.

专利号:US-2010160244-A1
优先权日:2004-09-02
标 题 :Methods and compositions for enhancing collagen, proteoglycan, and glutathione synthesis in the skin
发明人:NIMNI MARCEL; HAN BO
权利人:NIMNI MARCEL; HAN BO
摘要:A composition for application to the skin can stimulate the in vivo synthesis of collagen and proteoglycans and improve the appearance of the skin, increasing its elasticity and fullness. In general, a composition according to the present invention comprises: (1) an antioxidant compound in a quantity sufficient to enhance collagen synthesis in the skin; (2) an organic penetrant in which the antioxidant compound is soluble in a sufficient quantity that a concentration of the antioxidant compound sufficient to enhance collagen synthesis can be applied topically and penetrate the skin; (3) a mixture of essential amino acids or hydrolyzed whey protein; (4) a supplemental source of sulfur; and (5) a topical pharmaceutically acceptable carrier. The antioxidant compound can be lipoic acid or a lipoic acid analogue or derivative. The organic penetrant is preferably benzyl alcohol. Other ingredients, such as esters of tocopherol and ascorbic acid, can be included.

专利号:US-2025206743-A1
优先权日:2022-03-25
标 题:Tyk2 inhibitor synthesis and intermediates thereof
发明人:MASSE CRAIG E; PHADKE AVINASH S; LAWSON JON P; LEVY STUART; YANG XIAOWEI; WU GUISHENG; FAN SHUFENG
权利人:TAKEDA PHARMACEUTICALS CO
摘要:Described herein are methods of synthesis of a tyrosine-protein kinase 2 (TYK2) inhibitor and to intermediate compounds of the synthesis and methods of making the intermediates. Also provided are pharmaceutically acceptable compositions including compounds prepared by the synthetic method and methods of treating disorders using the same.
上海比阳实业有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.beyondindustriesgroup.com
企业联系电话:021-52699951👤
📞上海比阳实业有限公司 ⚠️参考联系方式
联系人:吴先生;莫先生
电话:021-52699951
手机:13917686115
传真:021-62570268
邮箱:sales@beyondindustriesgroup.com
通信地址: 上海市普陀区金沙江路1678弄绿洲中环中心6号楼
邮编: 200333
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:上海市普陀区金沙江路1678弄绿洲中环中心6号楼
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
湖南欧亚药业有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.hnouya.cn
企业联系电话:0592-5789920;19359986965👤
📞湖南欧亚药业有限公司 ⚠️参考联系方式
联系人:王磊
电话:0592-5789920;19359986965
手机:19359986965

邮箱:2851802013@qq.com
通信地址: 湖南省长沙市浏阳经济技术开发区康万路908号
邮编:
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:湖南省长沙市浏阳经济技术开发区康万路908号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Kakubari I, Sasaki H, Takayasu T, Yamauchi H, Takayama S, Takayama K. Effects of ethylcellulose and 2-octyldodecanol additives on skin permeation and irritation with ethylene-vinyl acetate copolymer matrix patches containing formoterol fumarate. Biol Pharm Bull. 2006 Aug;29(8):1717-22. doi: 10.1248/bpb.29.1717.
12:5203-5221. doi: 10.2147/IJN.S139975.

合成参考文献


摘要:S13 | EUCOSMETICS | Combined Inventory of Ingredients Employed in Cosmetic Products (2000) and Revised Inventory (2006) | DOI:10.5281/zenodo.2624118
摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198
摘要:Journal of the American College of Toxicology 4(5):1-29, 1985
摘要:International Journal of Toxicology 25(Suppl. 2) :1-89,2006
参考文献:10.1023/a:1016173303738
摘要:Shukla A, Janich M, Jahn K, Krause A, Kiselev MA, Neubert RH. Investigation of pharmaceutical oil/water microemulsions by small-angle scattering. Pharm Res. 2002 Jun;19(6):881–6. doi: 10.1023/a:1016173303738.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知